CLSA Funding
Data Collection and Biomarker inclusion
- 2021 to 2027
- Continued implementation of the approved CLSA protocol ($52M), including data collection for more than 50,000 participants for the period of 2021 to 2027. This six-year period will allow the team to collect data for the third follow-up (2021-2024) and the fourth follow-up (2024-2027).
Total amount funded by CIHR: $132,606,000
Protocol Implementation Investments:
- 2015 to 2021
- Continued implementation of the approved CLSA protocol ($52.8M), including data collection for all 50,000 participants for the period of 2015 to 2021. This six-year period will allow the team to collect data for first follow-up (2015-2018) and second follow-up (2018-2021).
- 2008-2015
- CLSA Team funded ($23.5 million) to support the Implementation Phase which includes the first wave of recruitment and baseline data collection from all 50,000 CLSA participants.
Protocol Development Investments:
- 2006-2008
- CLSA team funded ($2.1 million) to support Content Development and Validation
- 2004-2006
- Conduct of CLSA: Methodological Feasibility Studies
- Development and International Peer review of CLSA Protocol
- 2002-2004
- Development and International Peer review of CLSA Protocol Design
- CLSA Team funded ($1,744,000) to support the Methodological Feasibility Studies
- 2001-2002
- CIHR Institute of Aging issued a Request for Proposals (RFP) entitled: Protocol Design for the Canadian Longitudinal Study on Aging. The RFP was based on a CLSA Design Workshop held that same month in Aylmer, Quebec.
- Launch and International Peer review of Request for Proposals, entitled: Protocol Design for the Canadian Longitudinal Study on Aging.
- Meritorious CLSA team, headed by 3 principal investigators (Dr. Parminder Raina, McMaster University; Dr. Christina Wolfson, McGill University; and Dr. Susan Kirkland, Dalhousie University) funded ($462,000) to develop CLSA Protocol Design.
- Date modified: